Ireland pharmaceutical products over time
US$, annual.
In more detail
| Heading | Value | Share |
|---|---|---|
| 3002 Human blood | US$63.4 billion | 62.7% |
| 3004 Medicaments | US$33.3 billion | 32.9% |
| 3003 Medicaments | US$3.1 billion | 3.1% |
| 3006 Pharmaceutical goods | US$1.0 billion | 1.0% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$160.7 million | 0.2% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$122.2 million | 0.1% |
| Product | Value | Share |
|---|---|---|
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$52.6 billion | 52.0% |
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$29.2 billion | 28.9% |
| 300220 Vaccines: for human medicine | US$9.4 billion | 9.3% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$2.3 billion | 2.3% |
| 300339 Medicaments: containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale | US$2.3 billion | 2.3% |
| 300210 Blood: human and animal, antisera and other blood fractions | US$1.4 billion | 1.4% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$726.7 million | 0.7% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$696.1 million | 0.7% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$635.7 million | 0.6% |
| 300630 Pharmaceutical goods: opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | US$572.6 million | 0.6% |
| Heading | Value | Share |
|---|---|---|
| 3002 Human blood | US$7.1 billion | 53.0% |
| 3004 Medicaments | US$5.4 billion | 40.5% |
| 3003 Medicaments | US$663.5 million | 5.0% |
| 3006 Pharmaceutical goods | US$111.7 million | 0.8% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$83.3 million | 0.6% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$10.0 million | 0.1% |
| Product | Value | Share |
|---|---|---|
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$5.9 billion | 44.3% |
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$4.7 billion | 35.1% |
| 300220 Vaccines: for human medicine | US$755.0 million | 5.7% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$597.0 million | 4.5% |
| 300210 Blood: human and animal, antisera and other blood fractions | US$363.8 million | 2.7% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$256.8 million | 1.9% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$184.5 million | 1.4% |
| 300450 Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | US$162.5 million | 1.2% |
| 300339 Medicaments: containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale | US$61.6 million | 0.5% |
| 300630 Pharmaceutical goods: opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | US$49.6 million | 0.4% |
Shares are of Ireland's pharmaceutical products in the same direction. See Pharmaceutical products for all countries or all of Ireland's trade.
More Ireland products
- 29 Organic chemicals
- 90 Optical, photographic, cinematographic, measuring, checking, medical or surgical instruments and apparatus
- 85 Electrical machinery and equipment and parts thereof
- 84 Machinery and mechanical appliances, boilers, nuclear reactors
- 88 Aircraft, spacecraft, and parts thereof
- 33 Essential oils and resinoids
- 27 Mineral fuels, mineral oils and products of their distillation
- 87 Vehicles
- 39 Plastics and articles thereof
- 04 Dairy produce
- 02 Meat and edible meat offal
- 38 Chemical products n.e.c.
Ireland pharmaceutical products: questions and answers
How much pharmaceutical products does Ireland export?
In 2024, Ireland exported US$101.1 billion of pharmaceutical products (HS chapter 30), 38.9% of its total exports. That ranks it 3 of 213 exporting countries in the data.
What are Ireland's biggest pharmaceutical products exports?
In 2024, the largest 4-digit headings were Human blood (3002, US$63.4 billion), Medicaments (3004, US$33.3 billion), Medicaments (3003, US$3.1 billion).
How much pharmaceutical products does Ireland import?
In 2024, Ireland imported US$13.3 billion of pharmaceutical products (HS chapter 30), 9.6% of its total imports. That ranks it 15 of 226 importing countries in the data.
What are Ireland's biggest pharmaceutical products imports?
In 2024, the largest 4-digit headings were Human blood (3002, US$7.1 billion), Medicaments (3004, US$5.4 billion), Medicaments (3003, US$663.5 million).
